全文获取类型
收费全文 | 690篇 |
免费 | 67篇 |
出版年
2023年 | 16篇 |
2022年 | 22篇 |
2021年 | 46篇 |
2020年 | 19篇 |
2019年 | 23篇 |
2018年 | 24篇 |
2017年 | 21篇 |
2016年 | 30篇 |
2015年 | 62篇 |
2014年 | 54篇 |
2013年 | 47篇 |
2012年 | 71篇 |
2011年 | 50篇 |
2010年 | 27篇 |
2009年 | 31篇 |
2008年 | 28篇 |
2007年 | 28篇 |
2006年 | 24篇 |
2005年 | 12篇 |
2004年 | 17篇 |
2003年 | 18篇 |
2002年 | 15篇 |
2000年 | 4篇 |
1999年 | 2篇 |
1998年 | 4篇 |
1997年 | 2篇 |
1996年 | 3篇 |
1995年 | 3篇 |
1992年 | 3篇 |
1980年 | 2篇 |
1976年 | 2篇 |
1968年 | 5篇 |
1967年 | 2篇 |
1958年 | 1篇 |
1957年 | 1篇 |
1955年 | 1篇 |
1954年 | 1篇 |
1949年 | 1篇 |
1948年 | 1篇 |
1939年 | 1篇 |
1936年 | 1篇 |
1934年 | 1篇 |
1933年 | 1篇 |
1932年 | 2篇 |
1929年 | 2篇 |
1928年 | 1篇 |
1926年 | 1篇 |
1924年 | 1篇 |
1922年 | 1篇 |
1911年 | 3篇 |
排序方式: 共有757条查询结果,搜索用时 15 毫秒
31.
Sandra Herout Mattias Mandorfer Florian Breitenecker Thomas Reiberger Katharina Grabmeier-Pfistershammer Armin Rieger Maximilian C. Aichelburg 《PloS one》2016,11(4)
BackgroundIt is unclear whether antiretroviral therapy (ART) should be initiated during acute HIV infection. Most recent data provides evidence of benefits of early ART.MethodsWe retrospectively compared the clinical and immunological course of individuals with acute HIV infection, who received ART within 3 months (group A) or not (group B) after diagnosis.ResultsAmong the 84 individuals with acute HIV infection, 57 (68%) received ART within 3 months (A) whereas 27 (32%) did not receive ART within 3 months (B), respectively. Clinical progression to CDC stadium B or C within 5 years after the diagnosis of HIV was less common in (A) when compared to (B) (P = 0.002). After twelve months, both the mean increase in CD4+ T cell count and the mean decrease in viral load was more pronounced in (A), when compared to (B) (225 vs. 87 cells/μl; P = 0.002 and -4.19 vs. -1.14 log10 copies/mL; P<0.001). Twenty-four months after diagnosis the mean increase from baseline of CD4+ T cells was still higher in group A compared to group B (251 vs. 67 cells/μl, P = 0.004).ConclusionsInitiation of ART during acute HIV infection is associated with a lower probability of clinical progression to more advanced CDC stages and significant immunological benefits. 相似文献
32.
Achim von Bomhard Alexander Els?sser Lucas Maximilian Ritschl Silke Schwarz Nicole Rotter 《PloS one》2016,11(2)
Vitrification of endothelial cells (MHECT-5) has not previously been compared with controlled slow freezing methods under standardized conditions. To identify the best cryopreservation technique, we evaluated vitrification and standardized controlled-rate -1°C/minute cell freezing in a -80°C freezer and tested four cryoprotective agents (CPA), namely dimethyl sulfoxide (DMSO), ethylene glycol (EG), propylene glycol (PG), and glycerol (GLY), and two media, namely Dulbecco''s modified Eagle medium Ham’s F-12 (DMEM)and K+-modified TiProtec (K+TiP), which is a high-potassium-containing medium. Numbers of viable cells in proliferation were evaluated by the CellTiter 96® AQueous One Solution Cell Proliferation Assay (Promega Corporation, Mannheim, Germany). To detect the exact frozen cell number per cryo vial, DNA content was measured by using Hoechst 33258 dye prior to analysis. Thus, results could be evaluated unconstrained by absolute cell number. Thawed cells were cultured in 25 cm2 cell culture flasks to confluence and examined daily by phase contrast imaging. With regard to cell recovery immediately after thawing, DMSO was the most suitable CPA combined with K+TiP in vitrification (99 ±0.5%) and with DMEM in slow freezing (92 ±1.6%). The most viable cells in proliferation after three days of culture were obtained in cells vitrificated by using GLY with K+TiP (308 ±34%) and PG with DMEM in slow freezing (280 ±27%). 相似文献
33.
Ye Zhu Maximilian Blum Uwe Hoff Tim Wesser Mandy Fechner Christina Westphal Dennis Gürgen Rusan Ali Catar Aurelie Philippe Kaiyin Wu Gordana Bubalo Michael Rothe Steven M. Weldon Duska Dragun Wolf-Hagen Schunck 《PloS one》2016,11(1)
Aim
20-hydroxyeicosatetraenoic acid (20-HETE) and epoxyeicosatrienoic acids (EETs) are cytochrome P450 (CYP)-dependent eicosanoids that play opposite roles in the regulation of vascular tone, inflammation, and apoptosis. 20-HETE aggravates, whereas EETs ameliorate ischemia/reperfusion (I/R)-induced organ damage. EETs are rapidly metabolized to dihydroxyeicosatrienoic acids (DHETs) by the soluble epoxide hydrolase (sEH). We hypothesized that sEH gene (EPHX2) deletion would increase endogenous EET levels and thereby protect against I/R-induced acute kidney injury (AKI).Methods
Kidney damage was evaluated in male wildtype (WT) and sEH-knockout (KO)-mice that underwent 22-min renal ischemia followed by two days of reperfusion. CYP-eicosanoids were analyzed by liquid chromatography tandem mass spectrometry.Results
Contrary to our initial hypothesis, renal function declined more severely in sEH-KO mice as indicated by higher serum creatinine and urea levels. The sEH-KO-mice also featured stronger tubular lesion scores, tubular apoptosis, and inflammatory cell infiltration. Plasma and renal EET/DHET-ratios were higher in sEH-KO than WT mice, thus confirming the expected metabolic consequences of sEH deficiency. However, CYP-eicosanoid profiling also revealed that renal, but not plasma and hepatic, 20-HETE levels were significantly increased in sEH-KO compared to WT mice. In line with this finding, renal expression of Cyp4a12a, the murine 20-HETE-generating CYP-enzyme, was up-regulated both at the mRNA and protein level, and Cyp4a12a immunostaining was more intense in the renal arterioles of sEH-KO compared with WT mice.Conclusion
These results indicate that the potential beneficial effects of reducing EET degradation were obliterated by a thus far unknown mechanism leading to kidney-specific up-regulation of 20-HETE formation in sEH-KO-mice. 相似文献34.
Rhipsalis (Cactaceae): loss and gain of floral rewards is mirrored in range sizes and distribution patterns of species
下载免费PDF全文
![点击此处可从《Botanical journal of the Linnean Society. Linnean Society of London》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Bernadette Grosse‐Veldmann Stefan Abrahamczyk Jens Mutke Wilhelm Barthlott Maximilian Weigend 《Botanical journal of the Linnean Society. Linnean Society of London》2016,180(4):491-503
Autogamous species are usually distinguishable from xenogamous relatives by smaller flowers, fewer or even no floral rewards and lower pollen–ovule (P/O) ratios. Many Rhipsalis spp. are small flowered, selfing and include the most widespread species in Cactaceae. However, Rhipsalis also includes a large number of narrowly endemic species and is most diverse in the Atlantic rainforests of Brazil. To investigate the evolution of floral function and the correlation between floral function and range size, we analysed display size, floral reward and P/O ratios of Rhipsalis and its closest relatives, reconstructed ancestral traits and related these patterns to the distributions and range sizes of the species. Display size and sugar amount are reduced in subgenera Goniorhipsalis and Rhipsalis and secondarily increased in Phyllarthrorhipsalis, whereas the P/O ratio is decreased in subgenera Rhipsalis and Phyllarthrorhipsalis. We interpret this pattern as a switch from a predominantly xenogamous to an autogamous reproductive system, followed by a return to a predominantly xenogamous system. None of the floral parameters shows significant correlations with range size, except for display size. Nevertheless, those species with the smallest flowers, lowest sugar amounts per flower and lowest P/O ratios occur either outside southeastern Brazil and/or have comparatively large distribution ranges. Almost all Rhipsalis spp. occurring outside the Atlantic rainforests are restricted to the clade formed by subgenera Rhipsalis and Phyllarthrorhipsalis. Thus, we believe that the evolution of an autogamous reproduction system enabled this lineage of Rhipsalis to diversify and spread in the Atlantic rainforests, in the rest of the Neotropics and even spread to the Old World, where it is the only member of the family. 相似文献
35.
36.
Phillip J. Dugger Pedro G. Blendinger Katrin Bhning‐Gaese Lackson Chama Marta Correia D. Matthias Dehling Carine Emer Nina Farwig Evan C. Fricke Mauro Galetti Daniel García Ingo Grass Ruben Heleno Fbio A. F. Jacomassa Suelen Moraes Catherine Moran Marcia C. Muoz Eike Lena Neuschulz Larissa Nowak Augusto Piratelli Marco A. Pizo Marta Quitin Haldre S. Rogers Romn A. Ruggera Francisco Saavedra Mariano S. Snchez Rocío Snchez Vinicio Santilln Dana G. Schabo Fernanda Ribeiro da Silva Srgio Timteo Anna Traveset Maximilian G. R. Vollstdt Matthias Schleuning 《Global Ecology and Biogeography》2019,28(2):248-261
37.
38.
Helf Maximilian J. Freeman Michael F. Piel Jörn 《Journal of industrial microbiology & biotechnology》2019,46(3-4):551-563
Journal of Industrial Microbiology & Biotechnology - Polytheonamides are the most extensively modified ribosomally synthesized and post-translationally modified peptide natural products (RiPPs)... 相似文献
39.
Inhibition of TGF-beta2 with AP 12009 in recurrent malignant gliomas: from preclinical to phase I/II studies 总被引:4,自引:0,他引:4
Hau P Jachimczak P Schlingensiepen R Schulmeyer F Jauch T Steinbrecher A Brawanski A Proescholdt M Schlaier J Buchroithner J Pichler J Wurm G Mehdorn M Strege R Schuierer G Villarrubia V Fellner F Jansen O Straube T Nohria V Goldbrunner M Kunst M Schmaus S Stauder G Bogdahn U Schlingensiepen KH 《Oligonucleotides》2007,17(2):201-212
Transforming growth factor-beta2 (TGF-beta2) is known to suppress the immune response to cancer cells and plays a pivotal role in tumor progression by regulating key mechanisms including proliferation, metastasis, and angiogenesis. For targeted protein suppression the TGF-beta2-specific antisense oligodeoxynucleotide AP 12009 was developed. In vitro experiments have been performed to prove specificity and efficacy of the TGF-beta2 inhibitor AP 12009 employing patient-derived malignant glioma cells as well as peripheral blood mononuclear cells (PBMCs) from patients. Clinically, the antisense compound AP 12009 was assessed in three Phase I/II-studies for the treatment of patients with recurrent or refractory malignant (high-grade) glioma WHO grade III or IV. Although the study was not primarily designed as an efficacy evaluation, prolonged survival compared to literature data and response data were observed, which are very rarely seen in this tumor indication. Two patients experienced long-lasting complete tumor remissions. These results implicate targeted TGF-beta2-suppression using AP 12009 as a promising novel approach for malignant gliomas and other highly aggressive, TGF-beta-2-overexpressing tumors. 相似文献
40.
Pfingstl Tobias Wagner Maximilian Baumann Julia Neethling Jan Andries Bardel-Kahr Iris Hugo-Coetzee Elizabeth A. 《Organisms Diversity & Evolution》2022,22(3):789-801
Organisms Diversity & Evolution - The South African coast is known to harbor four different species of intertidal oribatid mites and their distribution strongly correlates with marine... 相似文献